Clinical trial
Q-POC SARS-CoV-2 Assay (Q27001) Clinical Performance Study Plan
NCT05614011 is registered in ClinicalTrials.gov with QuantuMDx Group Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Q-POC SARS-CoV-2 Assay (Q27001) Clinical Performance Study Plan
- Lead sponsor
- QuantuMDx Group Ltd
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 28, 2022
- Completion date
- May 17, 2023
- Enrollment
- 877 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.